Literature DB >> 30521874

Endonuclease G modulates the alternative splicing of deoxyribonuclease 1 mRNA in human CD4+ T lymphocytes and prevents the progression of apoptosis.

Dmitry D Zhdanov1, Yulia A Gladilina2, Vadim S Pokrovsky3, Dmitry V Grishin2, Vladimir A Grachev4, Valentina S Orlova4, Marina V Pokrovskaya2, Svetlana S Alexandrova2, Anna A Plyasova2, Nikolay N Sokolov2.   

Abstract

Apoptotic endonucleases act cooperatively to fragment DNA and ensure the irreversibility of apoptosis. However, very little is known regarding the potential regulatory links between endonucleases. Deoxyribonuclease 1 (DNase I) inactivation is caused by alternative splicing (AS) of DNase I pre-mRNA skipping exon 4, which occurs in response to EndoG overexpression in cells. The current study aimed to determine the role of EndoG in the regulation of DNase I mRNA AS and the modulation of its enzymatic activity. A strong correlation was identified between the EndoG expression levels and DNase I splice variants in human lymphocytes. EndoG overexpression in CD4+ T cells down-regulated the mRNA levels of the active full-length DNase I variant and up-regulated the levels of the non-active spliced variant, which acts in a dominant-negative fashion. DNase I AS was induced by the translocation of EndoG from mitochondria into nuclei during the development of apoptosis. The DNase I spliced variant was induced by recombinant EndoG or by incubation with EndoG-digested cellular RNA in an in vitro system with isolated cell nuclei. Using antisense DNA oligonucleotides, we identified a 72-base segment that spans the adjacent segments of exon 4 and intron 4 and appears to be responsible for the AS. DNase I-positive CD4+ T cells overexpressing EndoG demonstrated decreased progression towards bleomycin-induced apoptosis. Therefore, EndoG is an endonuclease with the unique ability to inactivate another endonuclease, DNase I, and to modulate the development of apoptosis.
Copyright © 2018 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Alternative splicing; Apoptosis; DNase I; EndoG; Lymphocytes

Mesh:

Substances:

Year:  2018        PMID: 30521874     DOI: 10.1016/j.biochi.2018.11.020

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

Review 1.  Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression.

Authors:  Ludmila Alekseeva; Nadezhda Mironova
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

2.  A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements.

Authors:  Julia Eberle; Rahel Stefanie Wiehe; Boris Gole; Liska Jule Mattis; Anja Palmer; Ludger Ständker; Wolf-Georg Forssmann; Jan Münch; J Christof M Gebhardt; Lisa Wiesmüller
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

Review 3.  Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.

Authors:  Anna A Plyasova; Dmitry D Zhdanov
Journal:  Biomedicines       Date:  2021-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.